Serum chemokine profiles in patients with alopecia areata

British Journal of Dermatology

Volumn 157, Issue 3, 2007, Pages 466-473

  Kuwano, Y ^a,b   Fujimoto, M ^c   Watanabe, R ^a   Ishiura, N ^a   Nakashima, H ^a   Ohno, Y ^a   Yano, S ^a   Yazawa, N ^a   Okochi, H ^b   Tamaki, K ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^c KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

Author keywords

Alopecia areata; Atopy; Chemokine; Monokine induced by interferon ; RANTES

Indexed keywords

CHEMOKINE; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES;

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; CYTOMETRY; DISEASE PREDISPOSITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSORIASIS VULGARIS;

ADOLESCENT; ADULT; AGED; ALOPECIA AREATA; CHEMOKINE CCL5; CHEMOKINES; DERMATITIS, ATOPIC; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MONOKINES; PSORIASIS;

EID: 34547899528     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.07943.x     Document Type: Article

References (18)

1. Cunliffe WJ, Hall R, Stevenson CJ et al. Alopecia areata, thyroid disease and autoimmunity. Br J Dermatol 1969 81 : 877 81.
2. Ikeda T. A new classification of alopecia areata. Dermatologica 1965 131 : 421 45.
3. Penders AJ. Alopecia areata and atopy. Dermatologica 1968 136 : 395 99.
4. Shellow WV, Edwards JE, Koo JY. Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol 1992 31 : 186 9.
5. Hoffmann R, Wenzel E, Huth A et al. Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994 103 : 530 3.
6. Arca E, Musabak U, Akar A et al. Interferon-gamma in alopecia areata. Eur J Dermatol 2004 14 : 33 6.
7. Abramovits W. Atopic dermatitis. J Am Acad Dermatol 2005 53 : S86 93.
8. Murphy PM, Baggiolini M, Charo IF et al. International Union of Pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 2000 52 : 145 76.
9. Kaburagi Y, Shimada Y, Nagaoka T et al. Enhanced production of CC-chemokines (RANTES, MCP-1, MIP-1alpha, MIP-1beta, and eotaxin) in patients with atopic dermatitis. Arch Dermatol Res 2001 293 : 350 5.
10. Kimata H, Lindley I. Detection of plasma interleukin-8 in atopic dermatitis. Arch Dis Child 1994 70 : 119 22.
11. Olsen EA, Hordinsky MK, Price VH et al. Alopecia areata investigational assessment guidelines - Part II. National Alopecia Areata Foundation. J Am Acad Dermatol 2004 51 : 440 7.
12. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980 92 (Suppl. 44 7.
13. Benoit S, Toksoy A, Goebeler M et al. Selective expression of chemokine monokine induced by interferon-gamma in alopecia areata. J Invest Dermatol 2003 121 : 933 5.
14. Qin S, Rottman JB, Myers P et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J Clin Invest 1998 101 : 746 54.
15. Suzuki N, Nakajima A, Yoshino S et al. Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999 11 : 553 9.
16. Alam R, Stafford S, Forsythe P et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993 150 : 3442 8.
17. Kimata H, Yoshida A, Ishioka C et al. RANTES and macrophage inflammatory protein 1 alpha selectively enhance immunoglobulin (IgE) and IgG4 production by human B cells. J Exp Med 1996 183 : 2397 402.
18. Nickel RG, Casolaro V, Wahn U et al. Atopic dermatitis is associated with a functional mutation in the promoter of the C-C chemokine RANTES. J Immunol 2000 164 : 1612 16.